The University of Munich Lung Cancer Group Database: Design, profile of cohort and outcome analysis

European Journal of Medical Research

Volumn 12, Issue 10, 2007, Pages 520-526

  Kuehnl, Andreas ^a   Hocaoglu, Y ^a   Herzog, M ^a   Schmidt, M ^b   Hornung, H M ^a   Jauchi, K W ^a   Hatz, R ^a   Graeb, C ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cancer Registry; Database; Evidence based medicine; Lung cancer; Quality Management

Indexed keywords

CORTICOSTEROID; NICOTINE;

ADULT; ARTICLE; CANCER REGISTRY; COHORT ANALYSIS; DATA BASE; FEMALE; HUMAN; LUNG CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MORBIDITY; OUTCOME ASSESSMENT; RISK ASSESSMENT; SURGICAL MORTALITY; SURGICAL RISK; SURVIVAL TIME; TOBACCO DEPENDENCE;

DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 36148957504     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Fu JB, Kau TY, Severson RK, Kalemkerian GP. Lung cancer in women: analysis of the national Surveillance, Epidemiology, and End Results database. Chest 2005; 127(3): 768-777.
2. Hasson MA, Fagerstrom RM, Kahane DC, Walsh JH, Myers MH, Caughman C, Wenzel B, Haralson JC, Flickinger LM, Turner LM. Prostate LCaOCSTPT Design and evolution of the data management systems in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials 2000; 21(6 Suppl): 329S-348S.
3. Nakaya N, Goto K, Saito-Nakaya KS, Inagaki M, Otani T, Akechi T, Nagai K, Hojo F, Uchitomi Y, Tsugane S, Nishiwaki Y. The lung cancer database project at the national cancer center, Japan: Study design, corresponding rate and profiles of cohort. Jpn J Clin Oncol 2006; 36(5): 280-284.
4. Chassin MR. Quality of health care. Part 3: improving the quality of care. N Engl J Med 1996; 335(14): 1060-1063.
5. Bundestninisterium für Gesundheit und Soziale Sicherung §137: Qualitätssicherung bei zugelassenen Krankenhäusern Sozialgesetzbuch V der Bundesrepublik Deutschland 2005; Kap. 4(Abschn. 9): 2477-2482.
6. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidlines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/ Society of Critical Care Medicine. Chest 1992; 101(6):1644-1655.
7. Watanabe Y. TNM classification for lung cancer Ann Thorac Cardiovasc Surg 2003; 9(6): 343-350.
8. Nollert G, Reichart B. Quality Assurance in Cardiac Surgery: General and Own Concepts Herz 1996; 21(6): 383-388.
9. Ferguson TB, Dziuban SW, Edwards FH, Eiken MC, Shroyer LW, Pairolero, PC, Anderson RP, Grover FL. The STS National Database: Current Changes and Challenges for the New Millenium. Ann Thorac Surg 2000; 69: 680-691.
10. Vahl CF, Meinzinger P, Thomas G, Osswald BR, Hagl S. Quality Assurance in Cardiac Surgery: Eight Year Experience with a "Feedback-Control"-System in Heidelberg Herz 1996; 21(6): 371-382.
11. Alexiou C, Beggs D, Onyeaka P, Koddis K, Ghosh S, Beggs L, Hopkinson DN, Duffy JP, Morgan WE, Rocco G. Pneumonectomy for Stage I (T1N0 and T2NO) Nonsmall Cell Lung Cancer has Potent, Adverse Impact on Survival Ann Thorac Surg 2003; 76: 1023-1028.
12. Manser R, Wright G, Hart D, Byrnes G, Campbell DA. Surgery for early stage non-small cell lung cancer. Cochrane Database Syst Rev 2005; 1 (CD004699)
13. Reed MF, Molloy M, Dalton EL, Howington JA. Survival after resection for lung cancer is the outcome that matters. Am J Surg 2004; 188: 598-602.
14. van-Rens MTM, Riviere AB, Elbers HRJ, Bosch JMM. Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II and IIIA Chest 2000; 117: 374-379.
15. Gärtner V, Albes J, Brugger W, Budach W, Duda S, Friedel G, Hruska D, Sökler M, Uckmann FP. Bronchialkarzinom - Empfehlungen zur Diagnostik, Therapie und Nachsorge Sildwestdeutsches Tumorzentrum Tübingen 1999; 2: 1-27.
16. Schubert-Fritschle G, Hölscher G, Schmidt M, Eckel R, Engel J, Tretter W, Hölzel D. Jahresbericht 2001/2002. W. Zuckerschwerdt-Verlag München; 2002.
17. Friedel G, Gracter T, Haas V, Hammeltath H, Marini A, Stoelben E, Toomes H. Quality management in Thoracic Surgery for the surgical treatment of lung cancer: results of a pilot trial. Thoracic Surgical Science 2004; 1 (Doc02)
18. Licker MJ, Widikker I, Robert J, Frey JG, Spiliopoulos A, Ellenberger C, Schweizer A, Tschopp JM. Operative Mortality and Respiratory Complications after lung resection for cancer: Impact of chronic obstructive pulmonary disease and time trends. Ann Thorac Surg 2006; 81: 1830-1838.
19. Mina K, Byrne MJ, Ryan G, Fritschi L, Newman M, Joseph D, Harper C, Bayliss E, Kolybaba M, Jamrozik K. Surgical Management of lung cancer in Western Australia in 1996 and its outcomes. ANZ J Surg 2004; 74: 1076-1081.
20. Allen MS, Darling GE, Pechet TTV, Harpole DH. Mobility and Mortality of Major Pulmonary Resection in Patients with Early-Stage Lung Cancer: Initial Results of the Randomized, Prospective ACOSOG Z0030 Trial. Ann Thorac Surg 2005; 81: 1013-1020.
21. Ludwig C, Stoelben E, Olschewski M, Hasse J. Comparison of Morbidity, 30-Day Mortality and Long-Term Survival after Pneumonektomie and Sleeve Lobektomy for Non-Small Cell Lung Carcinoma. Ann Thorac Surg 2005; 79: 968-973.
22. Matsubara Y, Takeda S, Mashimo T. Risk stratification for lung cancer surgery. Impact of induction therapy and extended resection. Chest 2005; 128: 3519-3525.
23. Präuer HW, Müller C, Thetter O. Operative Behandlung des Bronchialkarzinoms. Tumorzentrum München: MANUAL Tumoren der Lunge und des Mediastinums 2003; 56-60.
24. Mountain CF. Revision in the International System for Staging Lung Cancer Chest 1997; 111 (6): 1710-1717.
25. Williams DE, Pairoleto PC, Davis CS. Survival of patients surgically treated for stage I lung cancer. J Thorac Cardiovasc Surg 1981; 82: 70-76.
26. Ichiose Y, Hara N, Ohta M. Is T factor of the TNM staging system a predominant prognostic factor in pathologic stage I non-small-cell lung cancer? A multivariant prognostic factor analysis of 151 patients. J Thorac Cardiovasc Surg 1993; 106: 90-94.
27. Padilla CV, Penalver JC. Surgical results and prognostic factors in early non-small cell lung cancer. Ann Thorac Surg 1997; 63: 324-326.
28. Deslauriers J, Grégoire J. Surgical therapy of early nonsmall-cell lung cancer. Chest 2000; 117: 104S-109S.